1. Home
  2. ORMP vs CODA Comparison

ORMP vs CODA Comparison

Compare ORMP & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • CODA
  • Stock Information
  • Founded
  • ORMP 2002
  • CODA 1994
  • Country
  • ORMP United States
  • CODA United States
  • Employees
  • ORMP N/A
  • CODA N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • ORMP Health Care
  • CODA Industrials
  • Exchange
  • ORMP Nasdaq
  • CODA Nasdaq
  • Market Cap
  • ORMP 90.2M
  • CODA 88.8M
  • IPO Year
  • ORMP N/A
  • CODA N/A
  • Fundamental
  • Price
  • ORMP $2.41
  • CODA $8.76
  • Analyst Decision
  • ORMP Hold
  • CODA Strong Buy
  • Analyst Count
  • ORMP 1
  • CODA 1
  • Target Price
  • ORMP N/A
  • CODA $11.00
  • AVG Volume (30 Days)
  • ORMP 99.1K
  • CODA 71.2K
  • Earning Date
  • ORMP 11-06-2025
  • CODA 09-15-2025
  • Dividend Yield
  • ORMP N/A
  • CODA N/A
  • EPS Growth
  • ORMP N/A
  • CODA 21.86
  • EPS
  • ORMP N/A
  • CODA 0.30
  • Revenue
  • ORMP $2,000,000.00
  • CODA $22,758,966.00
  • Revenue This Year
  • ORMP N/A
  • CODA $30.82
  • Revenue Next Year
  • ORMP N/A
  • CODA $20.84
  • P/E Ratio
  • ORMP N/A
  • CODA $29.18
  • Revenue Growth
  • ORMP N/A
  • CODA 24.78
  • 52 Week Low
  • ORMP $1.82
  • CODA $5.76
  • 52 Week High
  • ORMP $3.09
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 71.70
  • CODA 66.55
  • Support Level
  • ORMP $2.17
  • CODA $7.61
  • Resistance Level
  • ORMP $2.45
  • CODA $8.12
  • Average True Range (ATR)
  • ORMP 0.06
  • CODA 0.40
  • MACD
  • ORMP 0.03
  • CODA 0.05
  • Stochastic Oscillator
  • ORMP 88.24
  • CODA 96.43

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: